Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-08

Clinical Trial Update: Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD

View source ↗

Summary

A completed real-world study comparing the effectiveness and cost-effectiveness of Qvar (beclomethasone dipropionate) versus fluticasone propionate and budesoni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flovent (fluticasone propionate)
  • Pulmicort (budesonide)
  • QVAR (beclomethasone dipropionate inhalation aerosol)

Snippet

Sponsor: Research in Real-Life Ltd | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED